This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Mechanism

Authoring team

  • hyperuricaemia - may occur prior to treatment of myeloid tumours but usually occurs after treatment has started, when there is rapid lysis of malignant cells, release of large amounts of nucleoprotein and an increase in production of uric acid.

  • renal failure may occur as a result of intra- and/or extra- renal obstruction caused by deposition of uric acid crystals in the collecting ducts, pelvis and ureters (ureteric obstruction may respond to retrograde ureteric catheterization and lavage).

  • usual site for uric acid crystal deposition is the renal tubules.

Plasma urate levels are raised (above 0.75 mmol/l and as high as 4.5 mmol/l).


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.